Roche Holding AG (RHHVF) est une société cotée en bourse dans le Santé secteur, opérant dans le Drug Manufacturers - General secteur d'activité. Le siège social de l'entreprise est situé à Basel, Switzerland. Le PDG actuel est Thomas Schinecker.
RHHVF a date d'introduction en bourse 2009-02-13, 103,249 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $321.02B.
Roche Holding AG is a Swiss pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, infectious diseases, immunology, and respiratory conditions, serving patients globally. Through its diagnostics division, Roche provides in vitro diagnostic tests, instruments, and reagents for detecting diseases such as cancer, cardiovascular conditions, diabetes, and infectious diseases including COVID-19. The company also pursues innovative research collaborations, including partnerships focused on synthetic biology treatments for conditions like inflammatory bowel disease. As an integrated healthcare company, Roche combines its pharmaceutical innovation with diagnostic capabilities to address major healthcare challenges worldwide.
